|
Austria-Fr-Fr Azienda Directories
|
Azienda News:
- IovanceCares
IovanceCares provides comprehensive support to patients, caregivers, and healthcare providers throughout the Iovance treatment journey IovanceCares includes the IovanceCares Portal, IovanceCares Reimbursement and Patient Support, and IovanceCares Case Manager Team Call Center
- LI Cares
Javascript is disabled on your browser To view this site, you must enable JavaScript or upgrade to a JavaScript-capable browser
- Investigating TIL Therapy PBL Therapy for Cancer - Iovance . . .
Learn about our investigational tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy View our clinical trials and pipeline
- Login Template Title - Salesforce
Login Template TitleLoading × Sorry to interrupt CSS Error Refresh
- AMTAGVI (Lifileucel) Learn about AMTAGVI (Lifileucel)
IovanceCares provides comprehensive support to patients, caregivers, and healthcare providers IovanceCares includes the IovanceCares Portal, IovanceCares Case Managers and Call Center, and IovanceCares Patient Reimbursement Support
- My Apps
My Apps My Apps
- Patient Portal - Avance Care
Our digital patient portal lets you easily renew prescriptions, book appointments and message your provider 24 7 We also offer telehealth appointments with extended hours to avoid trips to the emergency room or urgent care
- Our Products - Iovance Biotherapeutics
U S Prescribing Information: www iovance com AMTAGVI_USPI Patient Information: www iovance com AMTAGVI_Patient_Information Patient Support: www IovanceCares com You may report side effects to Iovance at 1-833-400-4682 or to the FDA at 1-800-FDA-1088 or www fda gov medwatch These sites are intended for use by U S residents 18 years or older
- Blue Mountain Regulatory Asset Manager
IOVANCE CLOUD AUTHENTICATIONPRODUCTION
- TIL and PBL Therapy Clinical Trials – Iovance Biotherapeutics
Iovance is investigating the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy as monotherapy and as part of combination therapy in advanced solid tumor cancers including melanoma, non-small cell lung cancer (NSCLC) and gynecologic cancers
|
|